Global Vaginal Ring Market 2018-2022
出 版 商：Technavio
出版日期：2018/07/11
頁 數：102頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
About Vaginal Ring
Vaginal rings are placed inside the vagina, and they release continuous doses of estrogen and progestogen into the bloodstream to prevent pregnancy. These rings also have non-contraceptive applications such as symptomatic relief during menopause and management of hormonal imbalance in individuals with polycystic ovary syndrome (PCOS).
Technavio’s analysts forecast the global vaginal ring market to grow at a CAGR of 2.96% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global vaginal ring market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of vaginal rings through pharmacies and clinics, and online retail across geographies.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Vaginal Ring Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ ALLERGAN
‧ Merck & Co.
‧ Novo Nordisk
‧ Pfizer
Market driver
‧ Growing importance of family planning
‧ For a full, detailed list, view our report
Market challenge
‧ Disadvantages and side effects of vaginal rings
‧ For a full, detailed list, view our report
Market trend
‧ Increase in innovative marketing strategies
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Vaginal rings are placed inside the vagina, and they release continuous doses of estrogen and progestogen into the bloodstream to prevent pregnancy. These rings also have non-contraceptive applications such as symptomatic relief during menopause and management of hormonal imbalance in individuals with polycystic ovary syndrome (PCOS).
Technavio’s analysts forecast the global vaginal ring market to grow at a CAGR of 2.96% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global vaginal ring market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of vaginal rings through pharmacies and clinics, and online retail across geographies.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global Vaginal Ring Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ ALLERGAN
‧ Merck & Co.
‧ Novo Nordisk
‧ Pfizer
Market driver
‧ Growing importance of family planning
‧ For a full, detailed list, view our report
Market challenge
‧ Disadvantages and side effects of vaginal rings
‧ For a full, detailed list, view our report
Market trend
‧ Increase in innovative marketing strategies
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: MARKET SEGMENTATION BY DISTRIBUTION CHANNELS
‧ Segmentation by distribution channels
‧ Comparison by distribution channels
‧ Pharmacies and clinics – Market size and forecast 2017-2022
‧ Online retail – Market size and forecast 2017-2022
‧ Market opportunity by distribution channels
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Americas – Market size and forecast 2017-2022
‧ EMEA – Market size and forecast 2017-2022
‧ APAC – Market size and forecast 2017-2022
‧ Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 12: MARKET TRENDS
‧ High disposable income
‧ Increase in innovative marketing strategies
‧ Increasing efficiency of vaginal rings
PART 13: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 14: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ ALLERGAN
‧ Merck & Co.
‧ Novo Nordisk
‧ Pfizer
PART 15: APPENDIX
‧ List of abbreviation
Exhibit 01: Parent market
Exhibit 02: Global female contraceptives market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global vaginal ring market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global vaginal ring market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Distribution channels – Market share 2017-2022 (%)
Exhibit 19: Comparison by distribution channels
Exhibit 20: Pharmacies and clinics – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Pharmacies and clinics – Year-over-year growth 2018-2022 (%)
Exhibit 22: Online retail – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Online retail – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by distribution channels
Exhibit 25: Customer landscape
Exhibit 26: Global vaginal ring market – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top three countries in Americas
Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top three countries in EMEA
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top three countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: ALLERGAN overview
Exhibit 44: ALLERGAN – Business segments
Exhibit 45: ALLERGAN – Organizational developments
Exhibit 46: ALLERGAN – Geographic focus
Exhibit 47: ALLERGAN – Segment focus
Exhibit 48: ALLERGAN – Key offerings
Exhibit 49: Merck & Co. overview
Exhibit 50: Merck & Co. – Products segments
Exhibit 51: Merck & Co. – Organizational developments
Exhibit 52: Merck & Co. – Geographic focus
Exhibit 53: Merck & Co. – Segment focus
Exhibit 54: Merck & Co. – Key offerings
Exhibit 55: Novo Nordisk overview
Exhibit 56: Novo Nordisk – Business segments
Exhibit 57: Novo Nordisk – Organizational developments
Exhibit 58: Novo Nordisk – Geographic focus
Exhibit 59: Novo Nordisk – Segment focus
Exhibit 60: Novo Nordisk – Key offerings
Exhibit 61: Pfizer overview
Exhibit 62: Pfizer – Business segments
Exhibit 63: Pfizer – Organizational developments
Exhibit 64: Pfizer – Geographic focus
Exhibit 65: Pfizer – Segment focus
Exhibit 66: Pfizer – Key offerings
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: MARKET SEGMENTATION BY DISTRIBUTION CHANNELS
‧ Segmentation by distribution channels
‧ Comparison by distribution channels
‧ Pharmacies and clinics – Market size and forecast 2017-2022
‧ Online retail – Market size and forecast 2017-2022
‧ Market opportunity by distribution channels
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Americas – Market size and forecast 2017-2022
‧ EMEA – Market size and forecast 2017-2022
‧ APAC – Market size and forecast 2017-2022
‧ Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 12: MARKET TRENDS
‧ High disposable income
‧ Increase in innovative marketing strategies
‧ Increasing efficiency of vaginal rings
PART 13: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 14: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ ALLERGAN
‧ Merck & Co.
‧ Novo Nordisk
‧ Pfizer
PART 15: APPENDIX
‧ List of abbreviation
Exhibit 01: Parent market
Exhibit 02: Global female contraceptives market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global vaginal ring market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global vaginal ring market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Distribution channels – Market share 2017-2022 (%)
Exhibit 19: Comparison by distribution channels
Exhibit 20: Pharmacies and clinics – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Pharmacies and clinics – Year-over-year growth 2018-2022 (%)
Exhibit 22: Online retail – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Online retail – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by distribution channels
Exhibit 25: Customer landscape
Exhibit 26: Global vaginal ring market – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 30: Top three countries in Americas
Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top three countries in EMEA
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top three countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: ALLERGAN overview
Exhibit 44: ALLERGAN – Business segments
Exhibit 45: ALLERGAN – Organizational developments
Exhibit 46: ALLERGAN – Geographic focus
Exhibit 47: ALLERGAN – Segment focus
Exhibit 48: ALLERGAN – Key offerings
Exhibit 49: Merck & Co. overview
Exhibit 50: Merck & Co. – Products segments
Exhibit 51: Merck & Co. – Organizational developments
Exhibit 52: Merck & Co. – Geographic focus
Exhibit 53: Merck & Co. – Segment focus
Exhibit 54: Merck & Co. – Key offerings
Exhibit 55: Novo Nordisk overview
Exhibit 56: Novo Nordisk – Business segments
Exhibit 57: Novo Nordisk – Organizational developments
Exhibit 58: Novo Nordisk – Geographic focus
Exhibit 59: Novo Nordisk – Segment focus
Exhibit 60: Novo Nordisk – Key offerings
Exhibit 61: Pfizer overview
Exhibit 62: Pfizer – Business segments
Exhibit 63: Pfizer – Organizational developments
Exhibit 64: Pfizer – Geographic focus
Exhibit 65: Pfizer – Segment focus
Exhibit 66: Pfizer – Key offerings
